Answer
Aug 16, 2024 - 11:58 AM
Linagliptin is a medication used to manage type 2 diabetes by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which helps increase insulin release and decrease blood sugar levels. Unlike some other DPP-4 inhibitors, it is not primarily excreted through the kidneys, making it a suitable option for patients with renal impairment.